Form 8-K - Current report:
SEC Accession No. 0001140361-21-012968
Filing Date
2021-04-15
Accepted
2021-04-15 17:20:16
Documents
1
Period of Report
2021-04-09
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K brhc10022998_8k.htm 8-K 19607
  Complete submission text file 0001140361-21-012968.txt   21004
Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-11460 | Film No.: 21829391
SIC: 2834 Pharmaceutical Preparations